Recent articles

Summary The oral blood glucose-lowering drug rosiglitazone has had a turbulent history. After its authorisation, it was found that the risk of myocardial infarction was larger with rosiglitazone ...

Published studies into the effects of tocilizumab in the treatment of patients with COVID-19 differ greatly in the way they have been designed and conducted. Comparisons are hampered by difference ...

It is now 12 years ago that the first girls were vaccinated against human papilloma virus (HPV) under the Dutch government’s national vaccination programme, and by now more research has been under ...

SGLT-2 inhibitors are relatively new drugs for the treatment of type 2 diabetes mellitus. Ever since these SGLT-2 inhibitors have become available for the treatment of diabetes, their use has incr ...

Erlotinib (Tarceva®) was the first EGFR tyrokinase inhibitor to be authorized for the treatment of non-small-cell lung carcinoma (NSCLC). It enabled outpatient treatment, and has a more favourable ...

Vector vaccines are produced using a relatively new technology which, among other things,  involves genetic techniques. After the genome of a new virus has been sequenced, this technology enables ...

Several studies have examined the efficacy and adverse effects of amisulpride for patients with schizophrenia, and these studies have been included in several meta-analyses (including network meta ...

The use of apps as medical devices can be advantageous for both patients and care providers, on condition that these products are thoroughly investigated and conform to the requirements for medica ...